The Importance of Patient Adherence Data and How Digital Tools Can Improve Patient Outcomes Training Course

Course overview

Clinical trials rely on accurate, real world data (RWD) to validate the drug assessment efficacy program. As a result, all patient data endpoints related to the interaction with the drug are critical to the success of the trial. Historically, patient adherence has been undertaken using a combination of poor packaging material manual reporting. This approach has long been proved to be inefficient and inaccurate. In the worst-case scenario, the trial results can be distorted, and the study has been withdrawn. This can be a costly situation for sponsors to contemplate.

Just over ten years ago, sponsors began to realise the “pain” which is associated with poor adherence. This led to an industry push for new, innovative digital and medical technology solutions. Today, the market is flush with potential options which can be positioned in/around your drug (tablet) compound. During this course we will explore a wide range of adherence monitoring tools designs from around the world.

There will be a chance to engage in an open discussion to determine the value of remote patient adherence monitoring. You will also learn what’s next and how to stay ahead of the curve. 

Browse our extensive selection of Life Sciences training courses for industry-leading insights into a range of topics. These include Medical Devices, IVDs, Biotech and Biopharma, Animal Health and Pharmaceutical training courses.

Benefits of attending

• Explore a wide range of adherence monitoring tools designs from around the world
• Discuss the value of remote patient adherence monitoring
• Stay ahead of the curve and learn what’s next in this field
• Evaluate your adherence options, including Software-as-a Service (SaaS), medical technology, invasive or non-invasive, supply chain fit, UX, cost, timelines and accuracy and scalability
• Learn how better science delivers better outcomes

Who should attend?

The content will be applicable to the following biopharmaceutical professionals who help to design, develop and manage a clinical study from inception to commercialisation:

• VPs and managers
• Strategic leaders
• Data scientists and analysts
• Feasibility teams
• Study sets
• Clinical operations
• Regulatory
• Medical affairs
• IT and system integration
• Market access
• Pharmacovigilance and safety
• Diversity and inclusivity teams
• Finance teams and budget holders

Enrol/reserve